Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    GDC-0919
Show Display Options
Rank Status Study
1 Recruiting A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors
Condition: Solid Tumor
Interventions: Drug: Atezolizumab;   Drug: GDC-0919
2 Completed Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors
Condition: Solid Tumor
Intervention: Drug: GDC-0919

Study has passed its completion date and status has not been verified in more than two years.